Drug intelligence / Profile preview

{3-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-amino]-2-methyl-propyl}-phosphonic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the molecular formula C11H20N2O9P2 and a molecular weight of 386.23 g/mol[1][5]. It is structurally related to pyridoxal phosphate (vitamin B6 phosphate derivatives), featuring a pyridine ring substituted with hydroxy, methyl, and phosphonomethoxy groups, linked via an aminoalkane chain to another phosphonic acid moiety. The compound appears in chemical databases as an experimental or research molecule; there are no records of clinical use or approved therapeutic indications. Its mechanism of action is not described in available sources, but its structure suggests it may act as an analog or inhibitor in vitamin B6-dependent enzymatic pathways.

Other names
{3-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-amino]-2-methyl-propyl}-phosphonic acid(((2R)-1-(((3-hydroxy-2-methyl-5-(phosphonooxy)methyl)pyridin-4-yl)methyl)amino)propan-2-yl)oxy)phosphonic acid(3-(3-hydroxy–2-methyl–5-phosphonooxymethy–pyridin–4–ylmethyl)–amino–2–methyl-propyl)-phosphonic acid{[(2R)-1-[({3-hydroxy−2−methyl−5−(phosphonooxy)methy]pyridin−4−yl}methylene)amino]propan−2−yloxy} phosphonic acid

Beyond the preview

Go deeper on {3-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-amino]-2-methyl-propyl}-phosphonic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on {3-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-amino]-2-methyl-propyl}-phosphonic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call